It looks like the CDC is all about PCR testing:
Post# of 9122
https://www.cdc.gov/coronavirus/2019-ncov/lab...ories.html
Those of us who have been around for awhile know the advantages that the N-Assay (ELISA based) has over PCR.
With the $8.3B in funding recently passed and the beating CDC officials are getting from Congress for the fallout of not having sufficient testing kits available, I am praying that our little Company is given a shot in the spotlight to showcase what our tech can do.